← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2009Last known activity
Jul 15, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT05330884CollaboratorPhase 3Jul 15, 2022
- NCT04975945Lead sponsorPhase 4Aug 31, 2021
- NCT04975945Reponsible party - principal investigatorPhase 4Aug 31, 2021
- NCT06837012Sponsor investigatorPhase 4Jan 1, 2021
- NCT06837012CollaboratorPhase 4Jan 1, 2021
- NCT01041911Overall official - principal investigatorPhase 2Mar 1, 2010
- NCT01095640Overall official - principal investigatorN/AMar 1, 2009
Details
- Last known activity
- Jul 15, 2022